Concept |
DECOR id |
DECOR effectiveDate |
FHIR id |
FHIR definition |
FHIR type |
Demografische gegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.1 |
2017-03-30T15:30:34 |
onco-generic-dataelement-1 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-1 |
group |
Patiƫnt |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.2 |
2017-03-30T15:30:34 |
onco-generic-dataelement-2 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-2 |
group |
Naamgegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.3 |
2017-03-30T15:30:34 |
NL-CM-0.1.6 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.6 |
group |
Initialen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.4 |
2017-03-30T15:30:34 |
NL-CM-0.1.35 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.35 |
string |
Geslachtsnaam |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.5 |
2017-03-30T15:30:34 |
NL-CM-0.1.36 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.36 |
group |
Achternaam |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.6 |
2017-03-30T15:30:34 |
NL-CM-0.1.24 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.24 |
string |
PatientIdentificatienummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.7 |
2017-03-30T15:30:34 |
NL-CM-0.1.7 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.7 |
string |
Geboortedatum |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.8 |
2017-03-30T15:30:34 |
NL-CM-0.1.10 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.10 |
dateTime |
Geslacht |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.9 |
2017-03-30T15:30:34 |
NL-CM-0.1.9 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.9 |
choice |
Zorgaanbieder |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.10 |
2017-03-30T15:30:34 |
NL-CM-17.2.1 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.1 |
group |
ZorgaanbiederIdentificatieNummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.11 |
2017-03-30T15:30:34 |
NL-CM-17.2.2 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.2 |
string |
OrganisatieNaam |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.12 |
2017-03-30T15:30:34 |
NL-CM-17.2.3 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.3 |
string |
AfdelingSpecialisme |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.13 |
2017-03-30T15:30:34 |
NL-CM-17.2.7 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.7 |
choice |
TelefoonEmail |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.14 |
2017-03-30T15:30:34 |
NL-CM-17.2.6 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.6 |
group |
Contactgegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.15 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3414 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3414 |
group |
Telefoonnummers |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.16 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3415 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3415 |
group |
Telefoonnummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.17 |
2017-03-30T15:30:34 |
NL-CM-0.1.23 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.23 |
string |
NummerSoort |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.18 |
2017-03-30T15:30:34 |
NL-CM-0.1.22 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.22 |
choice |
EmailAdressen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.19 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3418 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3418 |
group |
EmailAdres |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.20 |
2017-03-30T15:30:34 |
NL-CM-0.1.20 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.20 |
string |
EmailSoort |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.21 |
2017-03-30T15:30:34 |
NL-CM-0.1.19 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.19 |
choice |
Adres |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.22 |
2017-03-30T15:30:34 |
NL-CM-17.2.5 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.5 |
group |
Adresgegevens |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.23 |
2017-03-30T15:30:34 |
zib1bbr-dataelement-3421 |
http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3421 |
group |
Straat |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.24 |
2017-03-30T15:30:34 |
NL-CM-0.1.12 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.12 |
string |
Huisnummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.25 |
2017-03-30T15:30:34 |
NL-CM-0.1.13 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.13 |
string |
Huisnummerletter |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.26 |
2017-03-30T15:30:34 |
NL-CM-0.1.40 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.40 |
string |
Huisnummertoevoeging |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.27 |
2017-03-30T15:30:34 |
NL-CM-0.1.41 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.41 |
string |
AanduidingBijNummer |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.28 |
2017-03-30T15:30:34 |
NL-CM-0.1.42 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.42 |
choice |
Postcode |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.29 |
2017-03-30T15:30:34 |
NL-CM-0.1.15 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.15 |
string |
Woonplaats |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.30 |
2017-03-30T15:30:34 |
NL-CM-0.1.14 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.14 |
string |
Gemeente |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.31 |
2017-03-30T15:30:34 |
NL-CM-0.1.16 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.16 |
string |
Land |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.32 |
2017-03-30T15:30:34 |
NL-CM-0.1.17 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.17 |
choice |
AdditioneleInformatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.33 |
2017-03-30T15:30:34 |
NL-CM-0.1.28 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.28 |
string |
AdresSoort |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.34 |
2017-03-30T15:30:34 |
NL-CM-0.1.11 |
http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.11 |
choice |
OrganisatieType |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.35 |
2017-03-30T15:30:34 |
NL-CM-17.2.4 |
http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.4 |
choice |
Multidisciplinair overleg |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.224 |
2017-03-30T15:30:34 |
onco-generic-dataelement-154 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-154 |
group |
Datum MDO-verslag akkoord |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.225 |
2017-03-30T15:30:34 |
onco-generic-dataelement-155 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-155 |
date |
Vraagstelling |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.226 |
2017-03-30T15:30:34 |
onco-generic-dataelement-156 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-156 |
string |
Aanwezigheid: specialismen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.227 |
2017-03-30T15:30:34 |
onco-generic-dataelement-157 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-157 |
choice |
Datum |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.229 |
2017-03-30T15:30:34 |
onco-generic-dataelement-160 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-160 |
date |
Diagnose en stadiƫring |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.230 |
2017-03-30T15:30:34 |
onco-generic-dataelement-161 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-161 |
group |
Mammacarcinoom |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.231 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-231 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-231 |
group |
Klinisch (cTNM) |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.246 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-246 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-246 |
group |
Lymfeklieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.260 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-260 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-260 |
group |
Klinisch positieve parasternale klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.264 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-264 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-264 |
choice |
Post-neoadjuvant Postoperatief (ypTNM) |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.334 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-334 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-334 |
group |
Tumor |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.335 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-335 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-335 |
group |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.336 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-336 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-336 |
choice |
Lokalisatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.337 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-337 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-337 |
choice |
ypT-diameter |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.338 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-338 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-338 |
quantity |
ypT4-kenmerken |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.339 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-339 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-339 |
choice |
Morfologie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.340 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-340 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-340 |
choice |
Graad |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.341 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-341 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-341 |
choice |
Pathologische respons primaire tumor |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.342 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-342 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-342 |
choice |
Snijvlak |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.343 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-343 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-343 |
choice |
Angioinvasie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.344 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-344 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-344 |
choice |
ypT |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.345 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-345 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-345 |
choice |
Receptorstatus |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.346 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-346 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-346 |
group |
ER-percentage |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.347 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-347 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-347 |
quantity |
PR-percentage |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.348 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-348 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-348 |
quantity |
HER2-status |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.349 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-349 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-349 |
choice |
Lymfeklieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.350 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-350 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-350 |
group |
Zijdigheid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.351 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-351 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-351 |
choice |
Positieve supraclaviculaire klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.352 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-352 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-352 |
choice |
Positieve infraclaviculaire klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.353 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-353 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-353 |
choice |
Positieve parasternale klieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.354 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-354 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-354 |
choice |
Aantal axillaire klieren met micro- en/of macrometastasen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.355 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-355 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-355 |
integer |
Aantal axillaire klieren met macrometastasen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.356 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-356 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-356 |
integer |
Aantal axillaire klieren met micrometastasen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.357 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-357 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-357 |
integer |
Extranodale groei SWK |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.359 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-359 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-359 |
choice |
Extranodale groei OKD |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.360 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-360 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-360 |
choice |
Topklier |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.361 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-361 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-361 |
choice |
ypN |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.362 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-362 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-362 |
choice |
Metastasen |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.363 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-363 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-363 |
group |
ypM |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.364 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-364 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-364 |
choice |
ypTNM |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.365 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-365 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-365 |
choice |
Soort genmutatie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.366 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-366 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-366 |
choice |
Beleid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.382 |
2017-03-30T15:30:34 |
onco-generic-dataelement-163 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-163 |
group |
Mammacarcinoom |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.383 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-383 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-383 |
group |
Surveillance |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.412 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-412 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-412 |
group |
Tijd verstreken sinds incidentiedatum |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.413 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-413 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-413 |
quantity |
Advies klinische studie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.414 |
2017-03-30T15:30:34 |
onco-generic-dataelement-164 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-164 |
choice |
Klinische studie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.415 |
2017-03-30T15:30:34 |
onco-generic-dataelement-165 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-165 |
string |
Beleid |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.416 |
2017-03-30T15:30:34 |
onco-generic-dataelement-166 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-166 |
string |
Motivatie afwijken richtlijn |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.417 |
2017-03-30T15:30:34 |
onco-generic-dataelement-168 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-168 |
choice |
Motivatie afwijken richtlijn anders |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.418 |
2017-03-30T15:30:34 |
onco-generic-dataelement-169 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-169 |
string |
Behandeling |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.419 |
2017-03-30T15:30:34 |
onco-generic-dataelement-171 |
http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-171 |
group |
Mammacarcinoom |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.420 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-420 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-420 |
group |
Chirurgie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.422 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-422 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-422 |
group |
Eerste re-excisie |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.424 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-424 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-424 |
choice |
Operatie lymfeklieren |
2.16.840.1.113883.2.4.3.11.31.1.77.2.2.426 |
2017-03-30T15:30:34 |
onco-mamma-dataelement-426 |
http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-426 |
choice |